Cargando…
The effect of gender on the clinical outcome of PD-1/PD-L1 inhibitor in advanced lung cancer patients
BACKGROUND: Programmed death protein-1/ligand-1 (PD-1/L1) inhibitors have widely used in the treatment of lung cancer. Some literatures indicated that different gender might not have equal immune response, but no agreement have reached on the issue. Hence, we performed a systematic review and meta-a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470728/ https://www.ncbi.nlm.nih.gov/pubmed/37653772 http://dx.doi.org/10.1097/MD.0000000000034849 |